Skip to content
Screener

Claritev Corporation CTEV Net Change in Cash

Net Change in Cash at other companies

Evolent Health, Inc. logo
Evolent Health, Inc.EVH
-$27.28M+72.7%
UnitedHealth Group logo
UnitedHealth GroupUNH
$584M
Conduent Incorporated logo
Conduent IncorporatedCNDT
-$11M
Definitive Healthcare Corp. logo
Definitive Healthcare Corp.DH
$13.34M+152%
Corvel logo
CorvelCRVL
$22.81M-27.4%
Phreesia logo
PhreesiaPHR
$2.57M-61.4%

Other financials

Income statement

See full
Revenue$257.5M+6.6%
Gross profit$189.8M+5.0%
Operating income$23.4M+41.2%
Net income-$59.2M+5.5%
EPS (diluted)-$3.49+8.4%

Balance sheet

See full
Cash & equivalents$27.7M-58.9%
Total debt$4.7B+1.0%
Total equity-$294.6M-638%
Total assets$4.8B-6.1%

Cash flow

See full
Operating cash flow$92.7M+51.3%
CapEx$38.1M+54.7%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$555.59M-45.3%
Enterprise value$5.2B-6.7%
P/S0.6×-0.5×

Profitability

See full
Gross margin73%-1.5pp
Operating margin-0.5%-0.3pp
Net margin-28.5%-10.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio0.0×

Where this comes from

Reported directly by Claritev Corporation in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The source filing: Claritev Corporation’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001793229-26-000067
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Proceeds from issuance of common stock under ESPP1,001749
Repurchases of treasury stock(3,503)
Net cash provided by financing activities37,28969,924
Net (decrease) increase in cash, cash equivalents and restricted cash(666)37,616
Cash, cash equivalents and restricted cash at beginning of period28,34129,672
Cash, cash equivalents and restricted cash at end of period$27,675$67,288
Cash and cash equivalents$14,373$56,390
Restricted cash13,30210,898

Item 1. Financial Statements

FAQ

What is Claritev Corporation's net change in cash?
Claritev Corporation (CTEV) reported net change in cash of -$7.05M in Q2 2026.
How has Claritev Corporation's net change in cash changed year-over-year?
Claritev Corporation's net change in cash decreased by 121.1% year-over-year, from $33.39M to -$7.05M.
What is the long-term trend for Claritev Corporation's net change in cash?
Over 2 years (2023 to 2025), Claritev Corporation's net change in cash has grown at a -93.0% compound annual growth rate (CAGR), from -$270.79M to -$1.33M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Ask your AI about Claritev Corporation's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude